Home healthcare provider Addus HomeCare (NASDAQ: ADUS) will be reporting earnings tomorrow after the bell. Here’s what investors should know.
Addus HomeCare beat analysts’ revenue expectations by 2.7% last quarter, reporting revenues of $297.1 million, up 7.5% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ sales volume estimates and a decent beat of analysts’ EPS estimates.
Is Addus HomeCare a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Addus HomeCare’s revenue to grow 21.1% year on year to $339.9 million, improving from the 11.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.33 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Addus HomeCare has missed Wall Street’s revenue estimates three times over the last two years.
Looking at Addus HomeCare’s peers in the senior health, home health & hospice segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Option Care Health delivered year-on-year revenue growth of 16.3%, beating analysts’ expectations by 6.1%, and Chemed reported revenues up 9.8%, topping estimates by 0.8%. Option Care Health traded down 2% following the results while Chemed was also down 6.9%.
Read our full analysis of Option Care Health’s results here and Chemed’s results here.
There has been positive sentiment among investors in the senior health, home health & hospice segment, with share prices up 4.9% on average over the last month. Addus HomeCare is up 8.2% during the same time and is heading into earnings with an average analyst price target of $135.70 (compared to the current share price of $105).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
